27 episodes

This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.

ACC CardiaCast American College of Cardiology

    • Medicine
    • 4.0 • 1 Rating

This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.

    ACC CardiaCast: Deep Dive – Mechanisms Behind the Association Between Influenza and Acute CV Events (Part 2 of the Flu and CVD series)

    ACC CardiaCast: Deep Dive – Mechanisms Behind the Association Between Influenza and Acute CV Events (Part 2 of the Flu and CVD series)

    In this episode, Scott Solomon, Ankeet Bhatt, Orly Vardeny, Mohammad Madjid, and Jay Udell take a step back to dive deeper into the mechanisms behind the association between influenza and acute cardiovascular events. Visit the Taking the Lead: Flu and Cardiovascular Disease hub for more information and resources.

    • 16 min
    ACC CardiaCast: The Intersection of Influenza and Cardiovascular Disease (Part 1 of the Flu and CVD series)

    ACC CardiaCast: The Intersection of Influenza and Cardiovascular Disease (Part 1 of the Flu and CVD series)

    In this episode, Scott Solomon, Ankeet Bhatt, and Orly Vardeny discuss the intersection of influenza and cardiology and why cardiovascular practitioners should be concerned about influenza, particularly in the era of coronavirus disease 2019. Visit the Taking the Lead: Flu and Cardiovascular Disease hub for more information and resources.

    • 12 min
    ACC CardiaCast: Application and Key Features of the 2020 Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With Type 2 Diabetes

    ACC CardiaCast: Application and Key Features of the 2020 Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Patients With Type 2 Diabetes

    In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the main features from the recently published 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and how to apply the key points from this document in your practice.

    Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.

    • 11 min
    ACC CardiaCast: How Do You Integrate the Use of GLP-1 RAs and SGLT2 Inhibitors Into Your Health Care Setting in a Multidisciplinary Way?

    ACC CardiaCast: How Do You Integrate the Use of GLP-1 RAs and SGLT2 Inhibitors Into Your Health Care Setting in a Multidisciplinary Way?

    In this episode, Christopher Granger is joined by Melissa Magwire, a registered nurse and Practice Manager at Saint Luke's Cardiometabolic Center Alliance, to discuss advances in how to optimally treat patients with diabetes and cardiovascular disease and how to spread the model for organizing this care across the United States.

    • 8 min
    ACC CardiaCast: The Intersection of CVD and Type 2 Diabetes: The Role of SGLT2 Inhibitors and GLP-1 RAs in Cardiology

    ACC CardiaCast: The Intersection of CVD and Type 2 Diabetes: The Role of SGLT2 Inhibitors and GLP-1 RAs in Cardiology

    In this episode, Christopher Granger is joined by endocrinologist Jennifer Green to discuss the role of GLP-1 receptor agonists and SGLT2 inhibitors in cardiology, what cardiologists need to know to use these drugs safely and effectively, and how important it is to understand their role in the use of these drugs

    • 11 min
    ACC CardiaCast: Mechanisms of Action of GLP-1 RAs and SGLT2 in the Care of Patients With Type 2 Diabetes and CVD

    ACC CardiaCast: Mechanisms of Action of GLP-1 RAs and SGLT2 in the Care of Patients With Type 2 Diabetes and CVD

    In this episode, Christopher Granger and Robert Eckel discuss how to improve the care of patients with type 2 diabetes and cardiovascular disease, including using antihyperglycemic drugs that have relatively recently been shown to have an important effect on reducing cardiovascular outcomes. Visit the CVRiD: Applying Emerging Science to Practice Hub to listen to the other episodes in the series and to access other educational content.

    • 12 min

Customer Reviews

4.0 out of 5
1 Rating

1 Rating

Top Podcasts In Medicine

Listeners Also Subscribed To